1. Universal Screening & Risk Prediction
Deploy public screening tools across primary care networks and integrate predictive equations (KFRE) to prioritize patients at high risk of progression.
A transformative nationwide framework shifting clinical practice from late-stage dialysis dependence toward proactive renal preservation, pre-emptive living transplantation, and scientific lifestyle rehabilitation.
Preventing kidney failure progression through early detection, aggressive etiologic treatment, nephrotoxin eradication, and delayed incremental starts.
Deploy public screening tools across primary care networks and integrate predictive equations (KFRE) to prioritize patients at high risk of progression.
Automate eGFR CKD-EPI reporting in diagnostic labs, detect early microvascular damage, and standardize proteinuria assessment.
Target the two primary causes of kidney failure through guideline-directed RAAS blockade, SGLT2i, and strict hemodynamic management.
Prevent acute-on-chronic kidney injury from converting to ESRD. Implement drug adjustments and intercept hazardous drug interactions.
Halt arbitrary eGFR-based early starts. Use residual kidney clearance to begin with gentle once- or twice-weekly dialysis, preserving residual renal function.
Establishing pre-emptive transplantation as the first-line standard of care, expanding living donor paired swaps, and eradicating alloimmunization barriers.
Transplantation must be initiated at CKD Stage 4 (eGFR < 20 mL/min), enabling patients to bypass the physical, immunological, and economic tolls of dialysis.
Living donor kidneys provide 15โ20+ years of graft survival. Expand paired kidney exchange for incompatible ABO/HLA donor-recipient pairs.
Blood transfusions generate cytotoxic anti-HLA antibodies that destroy transplant compatibility. Enforce strict IV iron and ESA protocols to avoid transfusions.
Compress cardiac, infectious, oncologic, and dental clearance timelines to under 90 days. Eliminate administrative delays through role-specific training.
Scientific dietary autonomy, cardiovascular protection, ultrafiltration safety, fistula preservation, advanced dialysis, and psychosocial support.
Give patients dietary autonomy. Provide tools to balance potassium, phosphorus, and sodium while safeguarding protein intake (1.2 g/kg/day).
Cap ultrafiltration rates to protect against myocardial stunning and cerebral ischemia. Optimize interdialytic dry weight systematically.
Arteriovenous fistulae reduce mortality and infection by >50% compared to central venous catheters. Enforce early referral and surveillance.
Mitigate frailty through routine functional gait assessments and safe mobilization. Diagnose sleep apnea affecting >50% of ESRD patients.
Support patients through the psychological burden of dialysis. Overcome pill burden and measure patient-reported satisfaction routinely.
Clear middle-to-large uremic molecules via Hemodiafiltration (HDF) and eliminate chronic inflammatory stimulus with ultrapure water systems.
Quarterly clinical benchmarks mandated across all regional health networks and dialysis facilities.
| Pillar | National Performance Indicator (KPI) | Target Benchmark | Clinical Reference & Policy Link |
|---|---|---|---|
| Pillar 1: Delay | KFRE Risk Assessment completed in CKD Stage 3โ5 | ≥ 90% Eligible Cohort | KFRE Calculator → |
| Pillar 1: Delay | Guideline-Directed Medical Therapy in Diabetic CKD | ≥ 85% Eligible Cohort | Diabetic Nephropathy → |
| Pillar 1: Delay | Evaluation for Incremental Dialysis in incident patients | 100% Incident Patients | Incremental Dialysis → |
| Pillar 2: Transplant | Pre-emptive Listing rate for patients with eGFR < 20 | ≥ 50% Incident ESKD | Kidney Transplant → |
| Pillar 2: Transplant | Sensitization Prevention (Avoidable Blood Transfusions) | < 5% While on Waitlist | Anemia Analysis → |
| Pillar 3: Lifestyle | Permanent Vascular Access Rate (AVF/AVG vs CVC) | > 80% AVF / < 10% CVC | Vascular Access HD-CL-001 → |
| Pillar 3: Lifestyle | Ultrafiltration Rate Safety Adherence (< 12 mL/kg/h) | ≥ 95% of Dialysis Runs | UFR Policy HD-CL-006-F4 → |
| Pillar 3: Lifestyle | Adequacy Compliance (spKt/V ≥ 1.2 or URR ≥ 65%) | ≥ 90% Maintenance Cohort | Kt/V Calculator → |